G3D-33661-33139
2 vaccinations
3 coded responses
11 check-ins
3 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 117 / NY
- Registered
- 2021-01-16
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-15
Dose 1 — Pfizer-BioNTech
-
2021-01-16
Registered in v-safe
-
2021-01-16
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Chills, Headache, Fatigue or tirednessAdult check-in
- 2021-01-17
- 2021-01-21
- 2021-01-29
-
2021-02-05
Dose 2 — Pfizer-BioNTech
-
2021-02-07
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, Nausea, DiarrheaAdult check-in
- 2021-02-08
- 2021-02-09
-
2021-02-11
Health check-in — days 1–6 daily, dose 2Feeling: Good · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-02-12
Survey response — day 7, dose 2MedDRA: Contusion — Feeling: Good · Muscle or body achesFree text: Bruising of unknown origin on legsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-07
Survey response — 3 months, dose 2MedDRA: Amenorrhoea, Autoimmune thyroiditis, Blood cholesterol increased, Blood thyroid stimulating hormone increased, Office visit, Pre-existing disease — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: Hashimotos disease (astronomical TSH level of 69) (baseline was 1.4), elevated cholesterol 440 total and baseline cholesterol was under 200 prior to receiving the vaccine. I also have not had a period since receiving the second dose and NOT PREGNANT · Healthcare visit (other): In person visit with primary, endocrinologist and cardiologistMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-07
Report sent to call center — 3 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2022-02-05
Survey response — 12 months, dose 2MedDRA: Arthritis, Chest pain, Hepatic enzyme increased, Hypothyroidism, Inflammation, Lipids increased, Malaise, Office visit — Feeling: Poor · Get care from a doctor or other healthcare professionalFree text: Symptoms: Severe inflammatory immune response to the second dose of Pfizer. Severe acute hypothyroidism, inflammation in joints, elevated liver enzymes, elevated lipid panel, all previously normal. Chest pain and malaise · Healthcare visit (other): Visit with my primary care providerMedDRA releases: 2024-11 · check-in free text available
-
2022-02-05
Report sent to call center — 12 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2022-02-07
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-15 | Pfizer-BioNTech | |
| 2 | 2021-02-05 | Pfizer-BioNTech |
Call center
2 call center cases
2 unsuccessful
Free text
Release 4 — day 7, dose 2
Systemic reaction (other): Bruising of unknown origin on legs
Release 8 — 3 months, dose 2
Symptoms: Hashimotos disease (astronomical TSH level of 69) (baseline was 1.4), elevated cholesterol 440 total and baseline cholesterol was under 200 prior to receiving the vaccine. I also have not had a period since receiving the second dose and NOT PREGNANT cut off by CDC
Healthcare visit (other): In person visit with primary, endocrinologist and cardiologist
Release 11 — 12 months, dose 2
Symptoms: Severe inflammatory immune response to the second dose of Pfizer. Severe acute hypothyroidism, inflammation in joints, elevated liver enzymes, elevated lipid panel, all previously normal. Chest pain and malaise
Healthcare visit (other): Visit with my primary care provider
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | ✓ | ✓ | ✓ |
| SD | Amenorrhoea | ✓ | · | ✓ |
| SD | Arthritis | · | · | ✓ |
| SD | Autoimmune thyroiditis | ○ | ✓ | ○ |
| SD | Blood cholesterol increased | ✓ | ✓ | ✓ |
| SD | Blood thyroid stimulating hormone increased | ✓ | · | ✓ |
| SD | Chest pain | · | · | ✓ |
| SD | Hepatic enzyme increased | · | · | ✓ |
| SD | Hypothyroidism | · | · | ✓ |
| SD | Inflammation | · | · | ✓ |
| SD | Lipids increased | · | · | ✓ |
| SD | Malaise | · | · | ✓ |
| SD | Pre-existing disease | ✓ | · | ✓ |
| SRO | Contusion | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release